The novel approach of the medication represents a significant advance in the handling of diabetes mellitus type 2. Distinct from existing therapies, tirzepatide targets dual pathways – the GLP-1 hormone and the GIP https://tirzepatidepeptide059110.daneblogger.com/40649028/tirzepatide-peptide-a-new-frontier-in-diabetes-treatment